Is It Too Late to Buy Palantir Stock?
Key PointsPalantir is continuing to show strong growth.
Nasdaq Markets
History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio.
Key PointsAbbott has grown its earnings per share at a nearly 10% compound annual rate over the past decade.
Silver ETF Faceoff: Will SLV or SIL Give You Better Exposure to the Shiny Metal?
Key PointsiShares Silver Trust provides direct exposure to silver prices, while Global X - Silver Miners ETF invests in companies that extract the metal.
3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices
Key PointsTilray’s financial results have been weak for years.
The Nasdaq-100 Has Gained 20% or More 3 Years Running. This Streak Rests on Far Stronger Earnings Than 1999's.
Key PointsThe Nasdaq-100 has climbed 20% or more for three calendar years straight, starting with a 54% gain in 2023.
Banco Bradesco's Head of PE and VC Purchases $1.7 Million Shares. Does This Signal the Brazilian Bank Is a Buy?
Key PointsThe executive purchased 96,702 shares for a total consideration of $1.7 million.
CrowdStrike vs. UiPath: Which Technology Stock Is a Better Buy in 2026?
Key PointsCrowdStrike continues to dominate the cybersecurity market with its integrated Falcon platform.
1 Reason the Meta Muse AI Agent Has the Upper Hand
Key PointsThanks to its massive ecosystem, Meta can indirectly generate ad revenue through its popular Muse AI agent.
Here's What History Says October Will Bring for Nike Stock
Key PointsNike's performance in October this decade has been a mixed bag.
Better Pharma ETF: iShares IHE vs. State Street XPH
Key PointsThe iShares U.S. Pharmaceuticals ETF is significantly more concentrated than the State Street SPDR S&P Pharmaceuticals ETF, with Eli Lilly accounting for 23.63% of the portfolio.
Here's the 1 Thing I'd Wait to See Before Buying SpaceX Stock.
Key PointsSpaceX’s AI losses are erasing Starlink’s profits.
Here's the Average Men's Social Security Benefit by Age
Key PointsThe average man's Social Security benefit was $2,282.28 as of December 2025.
Joby Just Flew an Aircraft Across the United States With No Pilot. Here's Why Wall Street Shrugged.
Key PointsJoby completed a 3,199-mile autonomous flight with zero pilot inputs.
Advanced Micro Devices vs. Qualcomm: Which Technology Stock Is a Better Buy in 2026?
Key PointsAdvanced Micro Devices is leveraging strategic partnerships with industry leaders to expand its footprint in the high-performance data center market.
Bitcoin ETF Inflows Are Soaring. But They Are Not Telling the Whole Story About What's Happening With Bitcoin.
Key PointsBitcoin ETFs have seen significant inflows in recent weeks.
The Best Stock to Invest $10,000 in Right Now
Key PointsDutch Bros grew Q2 revenue by 32% to $551 million, with same-shop sales up 8.3%, driven by real transaction growth rather than higher prices.
Could Buying This 1 Cryptocurrency Make You Rich?
Key PointsNEAR Protocol is up more than 230% for the year, making it a standout crypto performer in 2026.
Is SoundHound AI a Buy After the LivePerson Deal?
SoundHound AI (NASDAQ: SOUN) has a much larger enterprise opportunity after acquiring LivePerson. The critical question is whether OASYS can turn that expanded customer reach into cross-selling, higher recurring revenue, and improved economics before losses, declining legacy reve
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
Key PointsThe VanEck Biotech ETF and State Street SPDR S&P Pharmaceuticals ETF both carry an identical expense ratio of 0.35%.
Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock?
Key PointsViking Therapeutics will soon enter phase 3 trials with its weight loss pill candidate.
This feed is responsible for generating the rss feed related to the topic Markets
Subscribe to Nasdaq Markets feed